Professor
Gladstone Institutes, University of California - San Francisco
Katerina Akassoglou is a Professor of Neurology at the University of California San Francisco, Senior Investigator at the Gladstone Institutes and Director of the Center for Neurovascular Brain Immunology at Gladstone and UCSF. She trained for her PhD at the Hellenic Pasteur Institute and the University of Vienna in Austria and performed postdoctoral studies at the Rockefeller University and New York University. She has pioneered studies in neuroimmunology and discovered neurovascular mechanisms of inflammation and tissue repair. Dr. Akassoglou discovered the role of the blood coagulation protein fibrin as a driver of neurodegeneration and developed a first-in-class fibrin-targeting immunotherapy for the treatment of neurological diseases, currently in Phase 1 clinical trials. She has published over 110 papers, is an inventor on 11 issued and several pending patents, and has delivered over 300 invited lectures. She was awarded by the White House the Presidential Early Career Award for Scientists and Engineers and her work has been recognized by several awards including the Barancik Prize and the Marilyn Hilton Award for Innovation in MS Research, ISFP Prize, Vilcek Prize Creative Promise honor and the Pharmacia-ASPET Award for Experimental Therapeutics. She is the scientific founder of the university spin-out Therini Bio and she was named by the San Francisco Business Times among the 2021 Most Influential Women in Bay Area Business. She is an elected Fellow of the American Society for Pharmacology and Experimental Therapeutics (ASPET), the National Academy of Inventors (NAI), and the American Association for the Advancement of Science (AAAS).
Disclosure information not submitted.
Blood Drivers of Thromboinflammation and Neuropathology in COVID-19
Thursday, June 26, 2025
2:10pm - 2:35pm East Coast USA Time
